Cargando…
A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants
Since the first case of Coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2019, SARS-CoV-2 infection has affected many individuals worldwide. Eventually, some highly infectious mutants—caused by frequent genetic recombination—have been reported...
Autores principales: | Rabaan, Ali A., Mutair, Abbas Al, Hajissa, Khalid, Alfaraj, Amal H., Al-Jishi, Jumana M., Alhajri, Mashael, Alwarthan, Sara, Alsuliman, Shahab A., Al-Najjar, Amal H., Al Zaydani, Ibrahim A., Al-Absi, Ghadeer Hassan, Alshaikh, Sana A., Alkathlan, Mohammed S., Almuthree, Souad A., Alawfi, Abdulsalam, Alshengeti, Amer, Almubarak, Fatimah Z., Qashgari, Mohammed S., Abdalla, Areeg N. K., Alhumaid, Saad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611209/ https://www.ncbi.nlm.nih.gov/pubmed/36298520 http://dx.doi.org/10.3390/vaccines10101655 |
Ejemplares similares
-
Antibodies to Combat Fungal Infections: Development Strategies and Progress
por: Rabaan, Ali A., et al.
Publicado: (2023) -
An Overview on Phenotypic and Genotypic Characterisation of Carbapenem-Resistant Enterobacterales
por: Rabaan, Ali A., et al.
Publicado: (2022) -
Seroprevalence, Risk Factors and Maternal–Fetal Outcomes of Toxoplasma gondii in Pregnant Women from WHO Eastern Mediterranean Region: Systematic Review and Meta-Analysis
por: Rabaan, Ali A., et al.
Publicado: (2023) -
Omics Approaches in Drug Development against Leishmaniasis: Current Scenario and Future Prospects
por: Rabaan, Ali A., et al.
Publicado: (2022) -
Genetic Variants and Protective Immunity against SARS-CoV-2
por: Rabaan, Ali A., et al.
Publicado: (2022)